This paper proposes that the phenomenon of anticipatory nausea and/or vomiting is a component of a phobic response to chemotherapy. Two cases are presented to highlight the clinical aspects of chemotherapy phobia. The evidence confirming such a diagnosis is put forth as it relates to anticipatory anxiety, phobic response, avoidance behaviour and treatment.
References
1.
AndrykowskiM.A.Defining anticipatory nausea and vomiting: differences among cancer chemotherapy patients who report pretreatment nausea.J Behav Med1988; 11: 59–69.
2.
MorrowG.R.Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients.J Nat Cancer Inst1982; 68: 585–588.
3.
LaszloJ., LucasV.S.Emesis as a critical problem in chemotherapy.N Engl J Med1981; 305: 948–949.
4.
MorrowG.R.Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment.J Clin Oncol1984; 2: 1170–1176.
5.
NerenzD.R., LeventhalH., EasterlingD.V.Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy.J Clin Oncol1986; 4: 224–233.
6.
DolginM.J., KatzE.R.Conditioned aversions in pediatric cancer patients receiving chemotherapy.Dev Behav Pediatrics1988; 2: 82–85.
7.
GreistJ.H., JeffersonJ.W., MarksI.M.Anxiety and its treatment.Washington, D.C.: American Psychiatric Press, 1986.
8.
Diagnostic and statistical manual of mental disorders, third edition, revised.Washington, D.C.: American Psychiatric Association,1987.
9.
CannonW.B.Bodily changes in pain, hunger, fear.New York: Appleton,1929.
10.
FettingJ.H., StefanekM.E., SheidlerV.E.Noradrenergic activity in anticipatory nausea.Proc ASCO1988; 7: 1101.
11.
FettingJ.H., SheidlerV.R., StefanekM.E.Phase I-IIa trial of clonidine for anticipatory nausea and vomiting.Proc ASCO1986; 5: 1026.
12.
MorrowG.R., ArsenaultJ.C., AsburyR.F.Anticipatory nausea and vomiting with chemotherapy.N Engl J Med1982; 306: 431–432.
13.
KatzI., BorysenkoJ.Z., ComeS.E.Paradoxical emetic response to antiemetic treatment in cancer patients.N Engl J Med1980; 303: 1480.
14.
MaherJ.Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy.Lancet1981; 1: 91.
15.
FriedlanderM., KearsleyJ.H., TattersalM.H.Oral lorazepam to improve tolerance to cytotoxic therapy.Lancet1981; 1: 1316.
16.
MorrowG.R., MorrellB.S.Behavioural treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy.N Engl J Med1982; 4: 1476–1480.
